Atıf Formatları
Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. DİNÇKAN, "Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients," IXth Congress of the Middle East Society for Organ Transplantation , vol.2, Ankara, Turkey, pp.45, 2004

DİNÇKAN, A. 2004. Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients. IXth Congress of the Middle East Society for Organ Transplantation , (Ankara, Turkey), 45.

DİNÇKAN, A., (2004). Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients . IXth Congress of the Middle East Society for Organ Transplantation (pp.45). Ankara, Turkey

DİNÇKAN, AYHAN. "Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients," IXth Congress of the Middle East Society for Organ Transplantation, Ankara, Turkey, 2004

DİNÇKAN, AYHAN. "Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients." IXth Congress of the Middle East Society for Organ Transplantation , Ankara, Turkey, pp.45, 2004

DİNÇKAN, A. (2004) . "Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients." IXth Congress of the Middle East Society for Organ Transplantation , Ankara, Turkey, p.45.

@conferencepaper{conferencepaper, author={AYHAN DİNÇKAN}, title={Low dose Mycophenolate Mofetil-Tacrolimus Regimen Increases Two-year Graft and Patient Survival in Renal Transplant Patients}, congress name={IXth Congress of the Middle East Society for Organ Transplantation}, city={Ankara}, country={Turkey}, year={2004}, pages={45} }